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Introduction
Semaphorins constitute a large family of signalling molecules,
conserved in evolution from invertebrates to humans, with over
twenty members in mammals. Semaphorins were originally
identified as axon repelling cues for the wiring of axonal
connections in the developing nervous system (Kolodkin et al.,
1993; Luo et al., 1993). Later it was shown that they can also
mediate attractive cues, through mechanisms that are still
unclear (Polleux et al., 2000; Moreno-Flores et al., 2003;
Pasterkamp et al., 2003; Masuda et al., 2004). Beyond their
established role in axon guidance, semaphorins are now known
to provide regulatory signals for a variety of other functions,
particularly cell migration (for a review, see Pasterkamp and
Kolodkin, 2003; Tamagnone and Comoglio, 2004). For
instance, the major developmental defects reported thus far in
semaphorin-deficient mice are probably due to the aberrant
migration of neural crest cells and endothelial cells (Behar et
al., 1996; Kawasaki et al., 1999; Brown et al., 2001; Feiner et
al., 2001).
Plexins are high affinity semaphorin receptors that occur
either alone or in complex with the neuropilins (Tamagnone et
al., 1999; Takahashi et al., 1999). Moreover, plexins and
neuropilins can form complexes on the cell surface with
receptor tyrosine kinases (such as Met, Ron, Otk and KDR)
and engage in multiple signalling pathways (Winberg et al.,
2001; Giordano et al., 2002; Conrotto et al., 2004; Toyofuku
et al., 2004). Nine plexins are known in humans, divided into
four subfamilies [plexins A to D (see Tamagnone et al., 1999)].
The cytoplasmic domain of plexins is highly conserved and it
is responsible for the functional response elicited by
semaphorins (Maestrini et al., 1996; Takahashi and
Strittmatter, 2001; Barberis et al., 2004). Its sequence is unique
and it shares no striking homology with other proteins or
known functional domains. However, it includes motifs with
moderate similarity to GTPase activating proteins (Rohm et al.,
2000) and it was recently demonstrated that it can exert GAP
activity on the small GTPase R-Ras (Oinuma et al., 2004). The
latter belongs to the superfamily of monomeric G proteins,
which are molecular switches shifting between an active GTP-
bound state and an inactive GDP-bound state (Etienne-
Manneville and Hall, 2002). While GTP/GDP exchange factors
(GEFs) are responsible for the functional activation of
GTPases, GTPase activating proteins (GAPs) serve as negative
regulators and lead to their functional inactivation (Bernards
and Settleman, 2004). Besides R-Ras, GTPases of the Rho
family can associate with specific plexins (Hu et al., 2001;
Driessens et al., 2001; Zanata et al., 2002), and recent reports
suggest that these interactions have a role in regulating the
recruitment of additional signal transducers to the receptor
(Oinuma et al., 2003; Oinuma et al., 2004; Turner et al., 2004).
Moreover, it has been shown that plexin B1 (PLXNB1) and
plexin B2  (PLXNB2) can associate with exchange factors for
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Plexins are transmembrane receptors for semaphorins,
guiding cell migration and axon extension. Plexin
activation leads to the disassembly of integrin-based focal
adhesive structures and to actin cytoskeleton remodelling
and inhibition of cell migration; however, the underlying
molecular mechanisms are unclear. We consistently
observe a transient decrease of cellular RhoA-GTP levels
upon plexin activation in adherent cells. One of the main
effectors of RhoA downregulation is p190, a ubiquitously
expressed GTPase activating protein (GAP). We show that,
in p190-deficient fibroblasts, the typical functional
activities mediated by plexins (such as cell collapse and
inhibition of integrin-based adhesion) are blocked or
greatly impaired. Notably, the functional response can be
rescued in these cells by re-expressing exogenous p190, but
not a mutant form specifically lacking RhoGAP activity.
We furthermore demonstrate that semaphorin function is
blocked in epithelial cells, primary endothelial cells and
neuroblasts upon treatment with small interfering RNAs
that knockdown p190 expression. Finally, we show that
p190 transiently associates with plexins, and its RhoGAP
activity is increased in response to semaphorin stimulation.
We conclude that p190-RhoGAP is crucially involved in
semaphorin signalling to the actin cytoskeleton, via
interaction with plexins.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/118/20/4689/DC1
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RhoA (Rho-GEFs) and induce their activation and Rho
signalling pathways (Aurandt et al., 2002; Perrot et al., 2002;
Swiercz et al., 2002). Intriguingly, these interactions are
restricted to plexins of the B subfamily, and they are likely to
be involved in specific functions mediated by this subset of
semaphorin receptors.
In vitro, semaphorins have been mainly studied for their
ability to induce axonal collapse or cellular collapse, associated
with the retraction of a protruding leading edge [either the
axonal growth cone or the cell lamellipodium, respectively (see
Luo et al., 1993; Eickholt et al., 1999; Takahashi et al., 1999)].
The mechanisms leading to the cytoskeletal rearrangements
that drive this process have not been fully elucidated. However,
we have recently shown that plexin activation inhibits integrin
function by uncoupling focal adhesive complexes from the
actin cytoskeleton (Serini et al., 2003; Barberis et al., 2004).
This leads to pseudopodia retraction; it inhibits the protrusion
of the leading edge and negatively regulates directional cell
migration. It is well known that the assembly and maintenance
of focal adhesive structures depends on the interaction between
extracellular matrix components and integrins, as well as on
the regulatory role of molecules mediating the association
between integrins and the actin cytoskeleton, including
GTPases of the Rho family (for reviews, see Van Aelst and
Symons, 2002; Ridley et al., 2003; Raftopoulou and Hall,
2004). In particular, the stability of integrin-based adhesive
structures is regulated by RhoA signalling (Rottner et al., 1999;
Schwartz and Shattil, 2000). When lamellipodia are formed at
the leading edge, new integrin-based adhesion sites to the ECM
are established. However, this process is very dynamic in order
to allow for fast directional changes, and only a fraction of
these adhesive structures matures further into focal contacts
(Rottner et al., 1999). This latter step requires RhoA activation
and the formation of effective connections between the
adhesive complexes and contractile F-actin cables, which are
required to generate the tensile forces mediating cell shape
changes and cell body translocation. Two main RhoA effectors
are involved in this process: the formin molecule diaphanous
(Dia), which promotes actin polymerization, and Rho-
dependent kinase (or ROCK), which promotes myosin-
mediated actin contraction. However, RhoA inactivation is
required to release the tension on adhesive structures, leading
to their disassembly (Burgstaller and Gimona, 2004). Then,
upon disruption of cell-substrate contacts, the actin
cytoskeleton is rearranged and the migration machinery resets
to respond to a new directional signal. RhoA is also known as
a negative regulator of cellular protrusions, probably through
the induction of a stiff cortical actin network. In fact, upon
reduced RhoA activity, random cell protrusions are increased,
without resulting in efficient directional cell movement
(Worthylake and Burridge, 2003). This explains why inhibition
of RhoA signalling promotes axonal outgrowth and counteracts
growth cone repulsion (Bito et al., 2000), while it hampers
directional cell migration.
The role of RhoA activation and signalling in semaphorin-
dependent functions is very controversial. While it has been
reported that this signalling pathway is required for Sema4D
and B subfamily plexins (Hu et al., 2001; Aurandt et al., 2002;
Swiercz et al., 2002; Oinuma et al., 2003), there is evidence
that this is not the case for Sema3A and Sema3F (Jin and
Strittmatter, 1997; Kuhn et al., 1999; Arimura et al., 2000;
Atwal et al., 2003; Turner et al., 2004). Moreover, we have
recently shown that ROCK signalling is not required for
plexin-mediated collapse response in adherent cells (Barberis
et al., 2004) and in fact, upon its inhibition, the cells appeared
to be more prone to semaphorin-induced collapse. This
prompted us to further explore RhoA regulation in the pathway.
Here we report that, unexpectedly, cellular Rho-GTP levels
decrease upon plexin activation, consistent with the idea that
the functional response to semaphorins may be driven by RhoA
inactivation. One of the main effectors of localized Rho
downregulation is p190, a ubiquitously expressed GTPase
activating protein (GAP), under the control of plasma
membrane receptors and tyrosine kinases (Brouns et al., 2000).
p190 is also known as p190A, to distinguish it from p190B, an
homologous protein with similar activities but different
upstream regulatory mechanisms (Burbelo et al., 1998).
Previous evidence indicated that p190A (simply referred to as
p190 hereafter) has a crucial role in regulating cytoskeletal
dynamics, by inhibiting focal adhesions and myosin-mediated
contraction of F-actin cables (Vincent and Settleman, 1999;
Ren et al., 2000; Burgstaller et al., 2004). In addition, it was
reported that cells overexpressing p190 acquire a rounded
phenotype with long, beaded extensions (Tatsis et al., 1998),
which is similar to that observed upon semaphorin-induced cell
collapse. We show here that p190-Rho-GAP is recruited to
plexins and functionally activated upon ligand stimulation. We
also show that, in the absence of p190 or in the presence of a
mutant devoid of GAP activity, the functional response to
semaphorins is abrogated. Therefore, p190-RhoGAP is
identified here as a pivotal mediator of semaphorin signalling.
Materials and Methods
Cells
NIH-3T3 cells were grown in DMEM medium, supplemented with
10% heat-inactivated Colorado calf serum (Colorado Serum
Company). PC12 rat neuroblasts were grown in presence of 10%
horse serum plus 5% fetal bovine serum. Human umbilical vein
endothelial cells (HUVEC) were isolated from cannulated human
umbilical veins by treatment with collagenase (see Bussolino et al.,
1992); they were seeded onto culture dishes coated with 1%
gelatine, and maintained in complete endothelial growth medium
containing 2% FBS and growth factors (EGMTM-2; Cambrex Bio
Science Walkersville Inc.). Each culture was used only up to eight
population doublings. All other cell lines were cultured in DMEM
or RPMI media, supplemented with 10% fetal bovine serum
(Gibco), in a humidified atmosphere of 5% CO2 (or 10% for PC12).
Fibroblasts derived from p190-deficient mice were previously
described (Brouns et al., 2000) and wild-type counterparts were
cultured similarly.
Antibodies
EC-6.9 monoclonal antibody recognizing the extracellular domain of
PLXNB1 (and of a PLXNB1/A1 chimera) was used for
immunofluorescence analysis (Barberis et al., 2004). In western
blotting experiments, PLXNB1 was detected with IC-2 antiserum
(Barberis et al., 2004). Mouse anti-VSV antibodies (clone P5D4) and
anti-vinculin (clone VIN-1) were from Sigma. Anti-Myc (clone
9E10), anti-paxillin (clone 349), anti-Rho (26C4) and anti-actin
antibodies were obtained from Santa Cruz. Anti-p190 monoclonal
antibodies were from BD Transduction Laboratories. Anti-hCD31
(clone JC70A) was purchased from DAKO. Anti-Hsp90 antibodies
(SPA-830) were from StressGene Biotech. HRP-conjugated anti-
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mouse and anti-rabbit secondary antibodies were from Amersham
(Amersham, UK).
Expression of plexins and semaphorins in mammalian cells
PLXNB1 and its mutated forms, as well as PLXNA1, all contained a
VSV-G-tag at the N terminus. p190RhoGAP-GFP and
p190RhoGAPR1283A-GFP (expressed from pEGFP-C1 vector;
Clontech) were kindly provided by K. Burridge. cDNA transfections
in 293T cells were performed using the calcium phosphate method,
according to a protocol described previously (De Palma and Naldini,
2002). All other cell types were efficiently transduced using lentiviral
vectors carrying the specific cDNAs, subcloned into transfer plasmid
pRRLsin.cPPT.hCMV.Wpre (kindly provided by L. Naldini).
Lentiviral vector particles were generated in 293T cells by transient
transfection, as previously described (De Palma et al., 2002; Barberis
et al., 2004).
Pools of MDA-MB435 cells expressing myc-tagged forms of
semaphorin 3A (Sema3A), semaphorin 3F (Sema3F), and the
extracellular domain of semaphorin 4D (Sema4D) were obtained by
lentiviral-mediated gene transfer. For all other functional experiments,
a His-tagged version of the extracellular domain of Sema4D was
affinity purified from the conditioned medium of transfected CHO
producer cells, as previously described (Barberis et al., 2004).
Rho-GTP pull-down assays
Rho-GTP levels were measured with a modified version of the method
described by Ren et al. (Ren et al., 1999). Briefly, cells were lysed for
5 minutes at 4°C in extraction buffer (50 mM Tris, pH 7.4, 10 mM
MgCl2, 500 mM NaCl, 1% Triton X-100, 1 mM DTT), containing a
cocktail of protease inhibitors (10 g/ml each of aprotinin, leupeptin
and pepstatin, plus 1 mM phenylmethylsulphonyl fluoride) and 200
M sodium orthovanadate. Cleared lysates were incubated with
agitation at 4°C for 60 minutes with 30 g of GST-RBD-coated beads.
GST-RBD, a GST fusion protein containing the RhoA-binding
domain of rhotekin was previously purified from recombinant bacteria
as described (Ren et al., 1999). Samples were then washed three times
with 50 mM Tris, pH 7.4, 10 mM MgCl2, 150 mM NaCl, 1% Triton
X-100 and protease inhibitors (as above) and then submitted to
immunoblot analysis with anti-RhoA monoclonal antibodies. Lysates
used as input for pull-downs were equally analysed by
immunoblotting, as loading controls. Band intensity was measured
with Quantity One (BioRad).
Immunoprecipitation and western blotting
Cells were lysed with EB buffer (20 mM Tris-HCl pH 7.4, 5 mM
EDTA, 150 mM NaCl, 10% glycerol, 1% Triton X-100) containing a
cocktail of protease inhibitors (as above) and 1 mM sodium
orthovanadate. Cleared extracts were incubated with the indicated
antibodies in agitation for 2 hours at 4°C. The immunocomplexes
were collected with protein A Sepharose (Pierce), extensively washed,
and eluted in SDS-containing buffer. An aliquot of each lysate used
as input for the immunoprecipitation (IP) was treated similarly.
Samples were separated by SDS-PAGE under reducing conditions and
transferred to nitrocellulose membranes (Amersham). Western blot
analysis using the indicated antibodies was performed according to
standard protocols. Final detection was done with an ECL system
(Amersham). Band intensity was quantified with Quantity One
program (BioRad).
Immunofluorescence, immunocytochemistry and cell
quantification
Cells were cultured overnight on glass coverslips, previously coated
with 10 g/l fibronectin (Sigma). After the indicated treatments,
cells were fixed with 4% paraformaldehyde (PAF) in PBS for 10
minutes on ice. Cells were then permeabilized for 5 minutes on ice
with 0.2% Triton X-100 in PBS, washed and incubated with blocking
buffer (PBS supplemented with 2% goat serum; Vector Laboratories
Inc.) for 30 minutes at room temperature. Primary antibodies were
incubated with cells for 30 minutes. F-actin was stained with
fluorescein-labelled phalloidin (phalloidin-FITC; Sigma). Secondary
anti-mouse-IgG antibodies were conjugated with Alexa Fluor 546
(red) or with Alexa Fluor 488 (green), both from Molecular Probes.
Cells were examined and photographed using a Zeiss Axyoskope
Confocal microscope and a Biorad Confocal Imaging System.
Immunocytochemical staining was performed using standard
techniques. Briefly, after fixation with PAF and permeabilization,
endogenous peroxidase activity was blocked with 3% H2O2 for 10
minutes, followed by washing with PBS. After incubation with mouse
monoclonal primary antibody, cells were washed and incubated with
DAKOCytomation Envision® System labelled Polymer-HRP anti-
mouse for 30 minutes at room temperature. Cell staining was
eventually developed by incubation with 3,3-diaminobenzidine/H2O2
(Dako).
Quantification involved counting at least 100 cells in at least two
independent fields, per each experimental point. Experiments were
performed in duplicate or triplicate and repeated at least three times
with consistent results.
Cell-substrate adhesion and cell spreading assays
These assays were performed as described previously (Barberis et al.,
2004). Briefly, 1-5104 cells harvested in 1 mM PBS/EDTA and
resuspended in serum-free DMEM/0.2% BSA were dispensed into
96-microtiter wells (previously coated with 10 g/ml fibronectin) and
transferred to a cell culture incubator. After the indicated times, the
wells were gently washed twice with PBS, and the adherent cells were
fixed and subsequently stained with Crystal Violet and photographed
with a Leica DMLB microscope coupled to a Leica DC300F camera.
To quantify cell adhesion, the dye was eluted from adherent cells with
10% acetic acid, and the absorbance measured at 595 nm in a
microplate reader.
Cell migration assay
Cell motility was assayed using Transwell® chamber inserts (Costar)
with a porous polycarbonate membrane (8 M pore size) as described
previously (Barberis et al., 2004). The membrane was coated with 10
g/ml fibronectin for 2 hours, and then blocked with 0.2% BSA. Cells
were harvested from culture dishes by treatment with 1 mM EDTA
(in PBS) and resuspended in 2% FBS-containing medium.
Approximately 1105 cells were then allowed to migrate across the
porous membrane towards the lower chamber containing the indicated
factors (heregulin1, from Neomarkers Inc., and purified Sema4D) in
medium containing 10% FBS. Cell migration was allowed to occur
for 4-6 hours, in a cell culture incubator. Then, the cells adherent to
the upper side of the filter were mechanically removed, while those
that had migrated to the lower side were fixed with 11%
glutaraldehyde and stained with crystal violet. Cells were
photographed and the dye solubilized in 10% acetic acid to measure
absorbance at 595 nm in a microplate reader.
RNA interference
The expression of p190RhoGAP was silenced by means of small
interfering RNA (siRNA)-based technology, through lentiviral-
mediated DNA transfer. To this end, the lentiviral transfer plasmid
pCCLsin.PPT.hPGK.GFP.Wpre was used to express two independent
siRNAs targeting p190RhoGAP transcripts (5AAGGCAACCTG-
GGAGAGTAAC-3 and 5-AACCTGTCCATCTGCTTCTGG-3) or
an unrelated sequence as negative control, under the transcriptional












(Brummelkamp et al., 2002). Note that the vector carries an
independent GFP expression cassette, to allow for the identification
of transduced cells.
HUVEC chemorepulsion assay
HUVEC cell repulsion was measured as described previously
(Bielenberg et al., 2004), with the following modifications. HUVEC
cells were grown to confluence on gelatine-coated glass coverslips in
24-well cell culture dishes (Corning Inc.). The endothelial cell
monolayer was washed twice and 6103 MDA-MB435 tumour cells,
transduced with different semaphorins, were seeded onto it in EGM-
2 complete medium. Co-cultures were incubated for 48 hours, before
analysis. Cells were then fixed with PAF and subjected to
immunostaining. Semaphorin-secreting MDA-MB435 cells were
detected with anti-Myc-tagged antibodies; endothelial cells were
identified by GFP expression (associated with siRNA-transducing
vectors) or alternatively by immunocytochemical staining with anti-
CD31 antibodies. HUVEC-free areas were measured in at least three
independent low magnification fields per each condition, by using
ImageQuant software.
Neurite outgrowth in PC12 cells
For neural differentiation experiments, PC12 cells were grown in 48-
well plates (precoated with poly-L-lysine) at a density of 5103
cells/well in 10% FBS/DMEM. After 8 hours from seeding, purified
Sema4D was added to the medium either in the presence or absence
of NGF (7S, Roche Molecular Biochemicals). Neural differentiation
was quantified after 48 hours by counting the cells bearing one or
more neuritic processes of a length greater than its cell body diameter.
Measurement of p190-RhoGAP activation
Cells were washed twice with PBS and lysed in 50 mM Tris, pH 7.4,
10 mM MgCl2, 150 mM NaCl, 1% Triton X-100, 1 mM DTT, 10
g/ml each of aprotinin and leupeptin, 1 mM phenylmethylsulphonyl
fluoride, and 200 M ortovanadate. Lysates were clarified by
centrifugation for 10 minutes at 12,000 g, and the supernatants were
incubated for 60 minutes with glutathione-Sepharose coated with a
constitutively active form of Rho (Q63L) conjugated with GST,
previously purified from bacteria (Noren et al., 2003). The samples
were washed at least three times with lysis buffer, and bound proteins
were eventually analysed by SDS-PAGE, followed by
immunoblotting to detect p190-RhoGAP.
Results
While studying the molecular mechanisms mediating
semaphorin functions, we had previously observed that an
inhibitor of the RhoA effector kinase ROCK seemed to
facilitate plexin-mediated cell collapse (Barberis et al., 2004).
This was partly unexpected, considering other reports that
had shown RhoA activation in response to PLXNB1
stimulation; however, it led us to investigate further whether
a down-regulation of RhoA signalling could have a role in the
plexin pathway. We noticed that, in non-serum-starved cells
transfected with PLXNB1, Rho-GTP levels were basally
increased, compared to controls. Moreover, as shown in Fig.
1A, Rho-GTP decreased remarkably upon treatment with the
purified PLXNB1-ligand semaphorin 4D (Sema4D). RhoA
inactivation was clearly detectable after 5 minutes of
stimulation, consistent with the time when the collapse
response started in these cells (Fig. 1A). Beyond 30 minutes
of stimulation, Rho-GTP resumed basal levels or
occasionally increased (not shown). Sema4D-induced RhoA
inactivation was not observed in cells expressing the
functionally-inactive mutated receptor PLXNB1-R1 (see
Barberis et al., 2004) (data not shown). In addition, we
studied RhoA regulation in the pathway downstream of the
cytoplasmic domain of PLXNA1, by exploiting a previously
described PLXNB1/A1 chimeric receptor (Barberis et al.,
Journal of Cell Science 118 (20)
Fig. 1. Downregulation of RhoA-GTP in response to PLXNB1 activation. (A) NIH-3T3 fibroblasts either expressing PLXNB1 or mock
transfected, were treated with the ligand Sema4D (5 nM) for the indicated times. RhoA-GTP levels were measured by pull-down with rhotekin-
RBD-coated beads, followed by immunoblotting with anti-RhoA antibodies. Expression levels of RhoA and of the exogenous plexin in input
lysates are shown below. The amount of pulled-down GTP-RhoA relative to total RhoA levels in each condition is reported at the bottom, based
on band intensity quantification. (B) Measurement of RhoA-GTP levels by rhotekin-RBD pull-down, as above, in SKBR3 cells expressing
endogenous PLXNB1 and treated with 10 nM Sema4D for the indicated times. Relative amounts of active RhoA were measured as above and
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2004), and observed similar results to those for PLXNB1
(supplementary material Fig. S1).
We furthermore demonstrated that purified Sema4D elicited
RhoA inactivation in SKBR3 cells, which express endogenous
levels of PLXNB1 (Fig. 1B). Rho-GTP downregulation
occurred with slower kinetics in these cells, consistent with our
previous observation that the functional response peaks later in
SKBR3 cells compared with fibroblasts overexpressing the
receptor (Barberis et al., 2004).
Altogether, these data indicate that plexin signalling can
elicit Rho inactivation. However, is this relevant for the
functional response mediated by semaphorins? Indirect
evidence of this came from the observation that NIH-3T3
fibroblasts expressing constitutively active RhoQ63L, or
treated with lysophosphatidic acid (LPA) to increase Rho-GTP
levels, do not undergo cell collapse in response to PLXNB1
stimulation (Barberis et al., 2004).
It is known that the downregulation of Rho-GTP levels is
largely mediated by p190-RhoGAP [p190A (Vincent and
Settleman, 1999)], an activator of the intrinsic GTPase activity
of Rho, acting under control of receptor-mediated signals
(referred to as p190 hereafter). Therefore, to directly assess
whether p190 has a role in plexin signalling, we studied the
previously described cell collapsing response (Barberis et al.,
2004) in cells deprived of p190 by expression of targeted small
interfering RNA (siRNA) sequences. NIH-3T3 cells expressing
PLXNB1 and undergoing collapse in response to Sema4D
were engineered by means of lentiviral vectors to express
siRNAs designed to selectively inactivate p190 transcripts or
targeted to an unrelated sequence as control. Cells expressing
p190-targeted siRNAs were found to have reduced levels of
p190-RhoGAP (Fig. 2A) and were refractory to Sema4D-
induced cell collapse (Fig. 2B), whereas cells expressing
control siRNAs displayed an efficient functional response,
indistinguishable from that of parental cells. Intriguingly, we
found that p190 is also required downstream of the cytoplasmic
domain of PLXNA1, since the functional response mediated
by the chimeric receptor PLXNB1/A1 (Barberis et al., 2004)
is impaired in p190-deficient fibroblasts (Fig. 2B, right panel).
Therefore, our results indicate that p190-RhoGAP is required
in the signalling pathway downstream of plexins of both the A
and B subfamilies. Analogous results were obtained by testing
semaphorin-induced collapse of COS cells similarly deprived
of p190 by expression of targeted siRNA (data not shown).
We have previously shown that the inhibition of integrin-
based adhesion is a pivotal step in semaphorin signalling. We
therefore tested whether the regulatory function of plexins on
integrin-mediated adhesion is dependent on p190. As shown in
Fig. 2. p190 Rho-GAP is required to mediate plexin signalling in fibroblasts. (A) Immunoblots of total cell lysates of NIH-3T3 fibroblasts
expressing PLXNB1 and engineered with siRNAs targeted to p190 transcript or to an unrelated sequence. The filter was probed with specific
antibodies directed against p190, PLXNB1 and actin. The endogenous levels of p190 are greatly reduced in NIH-3T3 fibroblasts by expression
of targeted siRNA, while plexin expression is unaffected. (B) NIH-3T3 fibroblasts expressing PLXNB1 (or PLXNB1/A1) and engineered with
p190-targeted siRNAs (or controls) were grown on glass coverslips and subjected to treatment with 5 mM Sema4D for 15 minutes. Cell were
then analysed by immunofluorescence with EC-6.9 antibodies directed against the extracellular domain of PLXNB1. Scale bar: 20 m. The
average fraction of collapsed cells was determined in each condition (Barberis et al., 2004) and it is shown on the right. Plexin-dependent
collapse response is greatly impaired in the absence of p190. (C) The attachment of the same cells as above to fibronectin-coated wells was
assayed, in the presence or absence of 5 nM Sema4D. After 30 and 120 minutes, adherent cells were fixed and stained with crystal violet. Cell
adhesion was eventually quantified by eluting the dye and measuring the absorbance at 595 nm. (D) In a similar experiment as described in C,
we scored the average fraction of fibroblasts spread on fibronectin, after 1 hour incubation with or without the indicated amounts of Sema4D












Fig. 2C, while Sema4D significantly inhibited the adhesion to
fibronectin of control cells, it was much less effective on cells
expressing reduced levels of p190. More importantly, control
cells could not extend lamellipodia and did not spread on the
surface in the presence of the semaphorin, while the spreading
of p190-deficient fibroblasts was significantly affected only at
high ligand concentrations (Fig. 2D). 
Notably, we could not obtain complete abrogation of p190
expression in NIH-3T3 fibroblasts; this may explain why the
functional response, although severely impaired, was not fully
blocked in these cells. We therefore turned to immortalized
fibroblasts derived from p190–/– mice (Brouns et al., 2000) for
further analysis. Notably, it was shown that these cells behave
similarly to wild-type counterparts in assays of cell
proliferation, cell adhesion to the ECM or cell migration
(Brouns et al., 2000); moreover, Rho-GTP levels are not
basally increased in these cells, presumably because of
adaptation (Wennerberg et al., 2003). Fig. 3A shows that these
Journal of Cell Science 118 (20)
Fig. 3. Re-expression of p190 Rho-GAP in gene-deficient cells restores the functional response to plexin activation. (A) Fibroblasts derived
from wild-type or from p190–/– mouse embryos (Brouns et al., 2000) were engineered to express PLXNB1 (see B for protein expression
analysis) and then treated with 10 mM Sema4D for 1 hour to test their collapse response (in analogy to Fig. 2B). Scale bar: 20 m. (B)
PLXNB1-expressing p190–/– knockout fibroblasts were engineered to express exogenous p190 or its inactive mutant p190RA (both conjugated
with GFP). Protein expression levels were analysed by immunoblotting with specific antibodies. Hsp90 expression was determined as loading
reference. (C) Merged fluorescence images of the cells described in B after treatment with 10 nM Sema4D for 30 minutes to induce cellular
collapse: the red channel reveals PLXNB1, detected with specific antibodies (EC-6.9), while the green channel shows p190-GFP. Co-expression
of PLXNB1 with p190, but not with its inactive mutant, is required and sufficient to rescue the functional response to Sema4D in these cells.
The asterisk marks a cell expressing PLXNB1 but not p190, which is insensitive to the ligand. Scale bar: 20 m. The fraction of GFP-positive
collapsed cells in each condition was counted and it is shown at the bottom. (D) p190-deficient fibroblasts expressing PLXNB1, and further
transfected with p190-GFP or its inactive mutant p190RA-GFP (the same shown in A), were grown on fibronectin-coated coverslips and treated
with 5 nM Sema4D for 5 minutes. Cells were then fixed and focal adhesions revealed in the red channel with anti-paxillin antibodies. After this
short stimulation, very few cells underwent collapse [consistent with that described in 3T3 fibroblasts (see Barberis et al., 2004)], however,
focal adhesions were disassembled in most of the cells expressing functionally competent p190-RhoGAP (identified by GFP expression). In
contrast, semaphorin stimulation had no effect in cells lacking p190 or expressing the mutant devoid of RhoGAP activity (p190RA). Scale bar:
20 m. The fraction of GFP-positive cells containing focal adhesion was counted and it is shown at the bottom. (E) Affinity purification of
RhoA-GTP (by rhotekin-RBD pull-down) from equal amounts of protein lysates of p190–/– fibroblasts expressing PLXNB1 and the indicated
exogenous p190 proteins, after treatment with 10 nM Sema4D for 15 minutes. Plexin-mediated Rho inactivation is abrogated in the absence of
p190, but it is rescued by expression of exogenous p190-GFP in the gene-deficient cells. The mutated form of p190 (p190RA), lacking GAP
activity, is unable to rescue the function. The effect was quantified by measuring the relative amounts of active RhoA in each condition (band
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cells failed to undergo collapse upon Sema4D
stimulation, in contrast to embryo fibroblasts derived
from wild-type animals and similarly engineered to
express PLXNB1. Moreover, plexin activation in p190-
deficient fibroblasts, unlike that seen in wild-type cells
(Barberis et al., 2004), did not induce the disassembly of
integrin-based focal adhesions, nor did it inhibit cell-
spreading on fibronectin (supplementary material Fig. S2
and data not shown). A brief treatment with 10 M
Y27632 (a selective ROCK inhibitor), however, could
induce major actin remodelling in these cells, as
expected, indicating that the downstream mechanisms
regulating cytoskeletal dynamics are preserved (data not
shown).
To provide evidence that the lack of p190 is specifically
responsible for abrogating plexin function in p190–/–
cells, we determined whether re-establishing its
expression could rescue the functional responses. We
therefore engineered gene-deficient fibroblasts to express
GFP-fusion proteins of either wild-type p190 or its
inactive form p190RA (Tatsis et al., 1998), carrying the
R1283A point mutation in the GAP domain (Fig. 3B). The
collapse response triggered by plexins was recovered by
the exogenous expression of p190-RhoGAP; by contrast,
the mutant form p190RA was ineffective, indicating that
the Rho-GAP activity of p190 is required in the plexin
signalling pathway (Fig. 3C). By immunostaining with
anti-paxillin antibodies (Fig. 3D), we furthermore
demonstrated that the expression of wild-type p190 (but
not p190RA) in gene-deficient fibroblasts is sufficient to
mediate the disassembly of integrin-based focal adhesive
structures, which precedes the collapse response induced
by plexin signalling (see Barberis et al., 2004). This
strongly suggests that the RhoGAP activity of p190
mediates the inhibition of integrin function induced by
semaphorins. Consistent with this conclusion, we also
found that cellular Rho-GTP levels where unchanged
upon plexin activation in p190-deficient cells, while this
mechanism was clearly rescued upon re-expression of
wild-type, but not mutated, p190 (Fig. 3E).
We have previously shown that a functional response
to purified Sema4D is also observed in epithelial cells
expressing endogenous levels of its receptor PLXNB1
(Barberis et al., 2004). Therefore, we assayed the functional
requirement for p190-RhoGAP in SKBR3 mammary
carcinoma cells. To this end, the downregulation of p190
protein was achieved by lentiviral-mediated expression of
small interfering RNAs (siRNA) selectively targeted to the
corresponding transcript (Fig. 4A). Fig. 4B shows that p190-
depleted SKBR3 cells cannot undergo collapse in response to
Sema4D, unlike parental cells (Barberis et al., 2004). In
addition, the previously described disassembly of adhesive
structures and inhibition of chemotaxis elicited by Sema4D in
these cells (Barberis et al., 2004) was severely impaired upon
siRNA-mediated knockdown of p190 (Fig. 4C). The
expression of control siRNA, directed against an unrelated
sequence, did not have any effect.
Semaphorins are known to regulate endothelial cell migration
and angiogenesis. In particular, it has been shown that Sema3A
and Sema3F mediate repulsion of primary endothelial cells
(HUVEC) and inhibit angiogenesis (Serini et al., 2003;
Bielenberg et al., 2004), via the function of neuropilins and
plexins of subfamily A and their regulatory activity on integrin-
mediated adhesion. To test whether these semaphorin-mediated
functions also depend on p190, we exploited a modified version
of the chemorepulsion assay in co-culture, described by
Bielenberg and coworkers (Bielenberg et al., 2004). We seeded
MDA-MB435 tumour cells, which had been engineered to
secrete different semaphorins (see Fig. 5A), onto confluent
monolayers of HUVEC cells that were either wild-type or
defective for p190-RhoGAP (due to expression of p190-
targeted siRNAs, see Fig. 5B). Tumour cells expressing
Sema3F induced repulsion of wild-type endothelial cells
[consistent with that reported by Bielenberg et al. (Bielenberg
et al., 2004)], as well as Sema3A-expressing cell, which were
extremely effective in our experiments (Fig. 5C, see also
supplementary material Fig. S3). Sema4D-expressing cells
induced a weaker repulsion of HUVECs, whereas mock-
transfected cells intercalated with endothelial cells without
inducing any substantial repulsion. Importantly, the down-
expression of p190 significantly reduced the retraction of
Fig. 4. p190 is required for multiple functional responses mediated by
Sema4D in epithelial cells expressing endogenous PLXNB1. (A) Selective
downregulation of p190 protein in SKBR3 cells by siRNA-mediated
technology, demonstrated by immunoblotting with specific antibodies. The
expression of endogenous PLXNB1 is unchanged. (B) Focal complex
disassembly (revealed by vinculin immunostaining) and cellular collapse
mediated by 1 hour treatment with 10 nM Sema4D was abrogated in p190-
depleted SKBR3 cells. The functional response was unaffected by siRNAs
targeting an unrelated sequence. The micrographs show results
representative of at least three independent experiments. Scale bar: 40 m.
(C) Chemotactic migration of SKBR3 treated with siRNAs (as above) was
assessed in Transwell® inserts, in the presence of 0.2 nM heregulin-1
(HRG), with or without 5  nM Sema4D. After 6 hours, the cells that had
migrated across the porous membrane were stained with Crystal Violet.
Cell migration was quantified by eluting the dye and measuring absorbance
at 595 nm. Results shown are the average of two independent experiments,
performed in duplicate. The expected inhibition of directional cell












endothelial cells in the presence of any of the
semaphorins. We quantified this effect by measuring
the HUVEC-free surface (Fig. 5D; see Materials and
Methods for quantification method). Our results
suggest that the directional retraction of endothelial
cells from areas containing semaphorins depends on
the activity of p190-RhoGAP, potentially mediating
a localized release of stable cell-substrate adhesions.  
Beyond its role in cell migration, the RhoGAP
activity of p190 has been implicated in neurite outgrowth in
neuroblasts in vitro (Brouns et al., 2001; Troller et al., 2004).
Intriguingly, among the functions mediated by semaphorins
(including Sema4D) is the ability to promote neurite outgrowth
from PC12 neural cells (Fujioka et al., 2003). We therefore
analysed whether p190 might be required to mediate this
response to Sema4D, by knocking down its expression through
siRNA-mediated technology. Notably, we did not observe
Journal of Cell Science 118 (20)
Fig. 5. p190 is required for semaphorin-induced
repulsion of primary endothelial cells. (A) MDA-MB435
mammary carcinoma cells were engineered to express
myc-tagged Sema3F, Sema3A, Sema4D or mock
transfected. The secretion of the semaphorins in the
conditioned medium as demonstrated by
immunoblotting with anti-myc antibodies. (B) HUVEC
cells were engineered to express siRNAs targeted to
p190 transcript or to an unrelated sequence. The
expression levels of p190 in cell lysates were then
analysed by immunoblotting with specific antibodies.
(C) siRNA-expressing HUVECs analysed as in B were
grown to confluence on glass coverslips. 6103 MDA-
MB435 tumour cells engineered to express the indicated
semaphorins (as shown in A) were then seeded onto the
monolayer of endothelial cells. After 48 hours of co-
culture, the cells were fixed and analysed by
immunofluorescence with anti-myc antibodies to reveal
semaphorin-expressing cells. HUVECs were identified
by GFP expression (associated with siRNA-expression
vectors). Scale bar: 200 m. In other experiments, the
endothelial cell monolayers were revealed by
immunocytochemistry with anti-CD31 antibodies
(supplementary material Fig. S3). (D) HUVEC-free
areas were identified by GFP expression or CD31
positivity (as described above) and measured by
ImageQuant software. At least three independent low
magnification fields were analysed, by two separate
investigators, for each experimental point. The table
shows average values. 
Fig. 6. p190 is required for Sema4D-induced neurite outgrowth. PC12 neuroblasts were grown for 48 hours in the presence of 50 ng/ml NGF,
with or without 1 nM Sema4D, and then fixed and photographed. Scale bar: 20 m. The bar chart shows the mean percentage of cells with
neurites (extending for at least one cell diameter) counted in three separate fields. Results are representative of two independent experiments.
As discussed in the text, PC12 neuroblasts displayed minimal (if any) functional response to treatment Sema4D only (not shown). However,
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significant phenotypic changes in PC12 cells expressing
siRNAs targeted to p190 transcript, compared with cells
expressing control siRNAs. Consistent with findings
reported by Fujioka and coworkers, control PC12
neuroblasts displayed minimal (if any) functional response
to treatment with Sema4D only (not shown), while purified
Sema4D synergized with nerve growth factor (NGF)
induced neurite outgrowth in PC12 cells expressing control
siRNAs. In contrast, as shown in Fig. 6, semaphorin
activity was completely lost in cells undergoing siRNA-
mediated p190 down-expression. Altogether, these results
point to p190-RhoGAP activation as a general mechanism
required for plexin signalling in different cells.
We then asked whether p190 is physically associated
with semaphorin receptor complexes. In co-
immunoprecipitation experiments, we demonstrated that
both PLXNA1 and PLXNB1 specifically associate with
p190-RhoGAP, and this requires the cytoplasmic domain
of the receptor (Fig. 7A). The association appears to be
constitutive upon protein overexpression. We thus tested the
association of PLXNB1 with endogenous p190 and found that,
while basally low, it was transiently increased upon stimulation
with the ligand Sema4D (Fig. 7B).
It was reported previously that the functional activation of
p190-RhoGAP is indicated by the increased ability to associate
with its substrate Rho-GTP (Noren et al., 2003). Therefore, we
used Sepharose beads coated with Rho-Q63L (a constitutively
active form always bound to GTP) to pull down functionally
activated p190-RhoGAP from lysates of cells treated with
Sema4D. As shown in Fig. 7C, upon plexin activation, the
association between p190 and its substrate was significantly
increased. This is consistent with evidence that p190 mediates
the down-regulation of Rho-GTP induced by plexins.
Discussion 
Semaphorins control a wide range of biological functions.
Moreover, some of them can induce antagonistic responses in
different cellular populations or experimental settings. For
example, the same semaphorin can either repel neuronal
processes (axons or dendrites) or attract them and induce their
outgrowth (e.g. Kolodkin et al., 1993; Polleux et al., 2000;
Swiercz et al., 2002; Schwamborn et al., 2004; Masuda et al.,
2004). In a similar manner, the same semaphorin can either
inhibit directional cell migration and induce apoptosis or
promote cell migration and cell survival (e.g. Giordano et al.,
2002; Toyofuku et al., 2004; Barberis et al., 2004). This is
consistent with an ability of semaphorins to trigger a range of
intracellular pathways. For most described functional
responses, it has been shown that plexins are a required
component of the receptor complex. However, other signalling
receptors can associate with plexins and have been implicated
in various biological outcomes.
The signalling pathways mediated by the conserved
cytoplasmic domain of plexins have not been fully elucidated.
In fact, although several putative signal transducers can interact
with plexins, for only a few of them has a ligand-dependent
Fig. 7. p190 is recruited to plexins, and its GAP activity is
induced upon receptor activation. (A) p190-GFP and either
PLXNB1 or PLXNA1 (VSV-tagged) specifically co-precipitate
from lysates of co-transfected 293T cells, whereas a truncated
form of PLXNB1 lacking the cytoplasmic domain (PlexinB1-
IC) does not associate with p190. Immunoprecipitations were
performed using either anti-tag antibodies (GFP for p190 and
anti-VSV for plexins, respectively) or non-related serum (nrs).
Western blots were probed with the indicated anti-tag or
protein-specific antibodies. Note that PLXNB1 is larger than
other plexins (approx. 300 kDa), while PlexinB1-IC and
PLXNA1 are almost identical in size (approx. 220 kDa).
(B) Co-immunopurification of endogenous p190 with
PLXNB1 transfected in 293T cells is induced after 5 minutes
stimulation with 5 nM Sema4D. The expression levels of p190
and PLXNB1 in cell lysates are shown at the bottom.
(C) Functionally active p190 was pulled-down (by means of
constitutive active RhoQ63L-GST coated beads) from lysates
of 3T3 fibroblasts expressing PLXNB1 and treated with 5 nM
Sema4D for the indicated times. Immunoblotting with specific
antibodies was used to detect p190 in pull-downs and in total
lysates (included as loading controls). As measured by band
density quantification, the level of activated p190 transiently












regulation been shown (Pasterkamp and Kolodkin, 2003).
While this manuscript was in preparation, it was reported that
the cytoplasmic domain of PLXNB1 associates with the
activated form of the small GTPase R-Ras, and promotes its
inactivation through an intrinsic R-Ras-GAP activity (Oinuma
et al., 2004). This is quite unique, since all other known GAP
proteins are recruited from the cytoplasm to protein complexes
in the plasma membrane. In this paper, we provide strong
evidence that the functional response mediated by plexins
requires p190-RhoGAP activity. The evidence that Rho-GTP
downregulation by p190 is required to mediate plexin function
is at least three-fold: (1) multiple functional responses to plexin
signalling, elicited in fibroblasts, tumour epithelial and primary
endothelial cells, and related to control of cell adhesion and cell
motility are abrogated in the absence of p190-RhoGAP; (2)
neurite outgrowth mediated by semaphorin stimulation of PC12
neuroblasts is abrogated upon knockdown of p190-RhoGAP;
(3) the functional response to semaphorins is rescued by re-
expressing p190 in gene-deficient cells, but not by re-expressing
a mutated form devoid of GAP activity. Furthermore, we
provided evidence that functional responses mediated by
different semaphorins, as well as by both cytoplasmic domains
of PLXNB1 and PLXNA1, require p190 activity, strongly
suggesting that this signalling pathway is shared by all family
members. Our evidence that p190 associates with plexins in
semaphorin receptor complexes clearly points to a direct
involvement of p190-RhoGAP activity in plexin signalling. We
also showed that, upon plexin activation, the association
between p190 and its substrate Rho-GTP is increased, and
accounts for the observed downregulation of active Rho.
Moreover, the kinetics of Rho-GTP downregulation is
consistent with that of the functional response observed in
fibroblasts engineered with plexins (approx. 10 minutes) and in
SKBR3 cells expressing endogenous PLXNB1 (approx. 30
minutes). It should be noted that, intriguingly, one of the
molecules associated with activated p190 is p120-RasGAP,
which can also use R-Ras as a substrate (Kinbara et al., 2003);
this could provide an additional mechanism to mediate R-Ras
inactivation upon plexin signalling.
It was reported that Rnd1/Rnd3 GTPases interact with p190
in vitro (in pull-down assays and in yeast two-hybrid assays)
and induce its GAP activity (Wennerberg et al., 2003).
Intriguingly, Rnd1 also associates with the cytoplasmic domain
of plexins (Rohm et al., 2000), and this seems to be a
prerequisite for the recruitment of additional plexin effector
molecules, such as R-Ras or Rho GEFs (Oinuma et al., 2003;
Oinuma et al., 2004). Nevertheless, we could not observe
changes in the association of p190 to PLXNB1 upon Rnd1
overexpression (not shown). Therefore, at the present time, we
are not able to determine whether ligand-induced association
of p190 with plexins is direct or depends on additional
intermediary molecules.
In apparent contradiction to our data, others have previously
reported increased Rho-GTP levels upon activation of plexins
of the B-subfamily. This effect is mediated by Rho Exchange
Factors associated with plexins (PDZ-Rho-GEFs), and requires
the tyrosine kinase activity of ErbB receptors, induced by
semaphorin treatment (Aurandt et al., 2002; Swiercz et al.,
2002; Swiercz et al., 2004). In fact, we found that the cytosolic
levels of active Rho are often increased in cells expressing high
levels of PLXNB1, which may be accounted by kinase-
dependent basal activation of PDZ-RhoGEFs. We have shown
here that soon after receptor stimulation, and consistent with
the time when the collapse response arises, RhoGTP levels
decrease. This effect is transient, and at later time points active
Rho resumes its initial levels (or even increases). Notably, to
reveal semaphorin-dependent activation of Rho-GEFs (and
Rho-GTP upregulation), cells must be subjected to extensive
serum-starvation in order to silence tyrosine kinase activities
and reduce Rho-GTP basal levels below detection threshold
(Swiercz et al., 2002). In these conditions, a further down-
regulation of RhoGTP induced by the ligand cannot be
detected. Notably, increased levels of active Rho were
observed following one hour in presence of Sema4D (Swiercz
et al., 2002), which is long after we observed Rho-GTP
downregulation (approx. 10 minutes), and long after cellular
collapse is triggered.
Altogether, the above evidence indicates that Rho-GTP
down-regulation and up-regulation elicited by plexins of the B
subfamily may derive from two independently regulated
pathways. However, how can they both have a role in
semaphorin signalling? One bit of direct evidence that Rho
activation may be required for certain functions is the finding
that the axonal collapse induced by Sema4D in hippocampal
neurons was blocked by Rho and ROCK inhibitors (Swiercz et
al., 2002). Nonetheless, we have recently shown that ROCK
activity is not required for Sema4D-mediated cellular collapse
(Barberis et al., 2004), and this is consistent with results
previously reported for growth cone collapse in response to
Sema3A and Sema3F (Jin et al., 1997; Kuhn et al., 1999;
Arimura et al., 2000; Atwal et al., 2003; Turner et al., 2004).
In fact, direct Rho activation might only occur downstream of
plexins of the B subfamily, which associate with RhoGEFs,
and therefore it is unlikely to play a role in the signalling
pathway downstream of other semaphorin receptors.
Interestingly, it was recently reported that the downregulation
of Rho-GTP levels correlates with PLXNA1-mediated
inhibition of endocardial cell migration (Toyofuku et al., 2004).
Here we found that p190-RhoGAP is required to mediate
plexin signalling in a range of cells, and that it is required for
plexin-induced Rho downregulation. Moreover, we show that
a mutant form of p190 that specifically lacks GAP activity and
cannot downregulate Rho-GTP is unable to mediate plexin
signalling. The functional requirement for p190 is observed not
only in plexin over-expressing cells, but also in immortalized
epithelial and neuronal cells, as well as in primary endothelial
cells, which express endogenous semaphorin receptors. Thus,
we propose that a transient inhibition of Rho signalling is a
common mechanism required for plexin-mediated cell
collapse, for the regulation of cell adhesion and cell migration,
and in neurite outgrowth induced by semaphorins. However,
Rho-GTP upregulation may be selectively elicited by plexins
of the B subfamily as an independent signalling pathway,
involved in specific functional responses.
Rho-GTP downregulation mediated by p190 may account for
F-actin depolymerization and cytoskeletal rearrangements
typically observed in semaphorin-treated cells and axonal
growth cones. In addition, we showed here that p190 is required
for the early inhibition of integrin function mediated by plexins,
which is crucially implicated in the control of cell migration and
angiogenesis. How can p190-RhoGAP mediate this effect?
Integrin-based complexes are very dynamic structures, as
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suggested by the fact that both inhibition of adhesion and the
inability to break adhesive complexes can hamper cell
migration (Webb et al., 2002). Interestingly, low levels of active
Rho at the leading edge guarantee a fast turnover of newly
formed adhesive sites, to allow changes in the direction of
migration induced by environmental guidance cues. However,
a major inhibition of Rho signalling at the cell membrane (such
as that mediated by p190 activation) can hamper the stability of
all adhesive complexes, by weakening their connection with the
contractile actin cytoskeleton (Burgstaller et al., 2004). When
presented non-directionally, these signals induce retraction of
all existing pseudopodia, or result in the appearance of random
poorly organized cell protrusions, and eventually lead to
impaired migration (Tatsis et al., 1998; Fincham et al., 1999;
Worthylake et al., 2003). However, when the same signals are
presented locally in a polarized manner, as we showed here in
the endothelial cell co-culture assay, they elicit directional cell
repulsion, probably explained by the selective retraction of
cellular processes closer to the factor inhibiting cell-substrate
adhesion (such as the semaphorins).
It remains to be determined whether Rho-GAP activity is also
important for semaphorin-mediated axon guidance in vivo. It
should be noted that the prevailing concept is that Rho
activation hampers axonal outgrowth, while Rho inhibition
promotes it. A localized turnover of Rho signalling, however,
might be required for the dynamic reshaping of growth cones
steering away from repelling signals and towards attractive
ones. The demonstration of localized defects in axon
pathfinding in p190 knockout mice (Brouns et al., 2000) is
consistent with such a hypothesis and merits further
investigation. Intriguingly, at least three semaphorins (Sema3A,
Sema3E and Sema4D) can induce both axonal collapse and
neurite outgrowth in different neuronal cells (Sakai et al., 1999;
Schwamborn et al., 2004; Masuda et al., 2004). While axonal
collapse and cellular collapse are fast functional responses
thought to share certain effector mechanisms, the signalling
pathways involved in semaphorin-mediated neurite outgrowth
were not known. Intriguingly, Rho inactivation by p190 can
induce neurite outgrowth by disassembling the cortical actin
network (Brouns et al., 2001), and in this paper we provide the
first evidence that the neurite outgrowth induced by
semaphorins requires p190-RhoGAP. Based on our results, we
thus conclude that p190-Rho-GAP is recruited to plexins upon
ligand stimulation and is a pivotal mediator of multiple
functional responses mediated by semaphorins.
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